Skip to main content
. Author manuscript; available in PMC: 2014 Mar 13.
Published in final edited form as: Oncogene. 2011 May 23;30(45):4590–4600. doi: 10.1038/onc.2011.166

Figure 2.

Figure 2

Inhibition of endogenous RasGRP3 expression retarded cell proliferation in multiple human melanoma cell lines. (A) Individual cell lines were transiently transfected with RasGRP3 siRNA pool and Control siRNA pool 1 at 80 nM final concentration. After 96 hours, cell proliferation was determined by using the CyQuant NF cell proliferation assay, with values normalized to the levels of untreated cells. Values represent the mean ± SEM for four independent experiments. Confirmation of the extent of suppression of RasGRP3 was determined by immunoblotting. Results are representative of 3 experiments. (B and C)The Tet-on stable cell lines created from the M14 and SK-MEL-5 cell lines were seeded at a density of 104 cells/ml in complete growth medium. Cells were treated with/without 1 μg/ml tetracycline for 120 hours and proliferation was determined by using the CyQuant NF cell proliferation assay, with values normalized to the levels of parental M14 or SK-MEL-5 cells. Values represent the mean ± SEM of four independent experiments. Endogenous RasGRP3 expression was determined by RT-PCR (M14) or immunoblot (SK-MEL-5) 120 hours after induction. Results are representative of three independent experiments.